Was at a recent "hiring event". Was downsized at Regeneron and agressively recruited to attend. Ended up just filling a spot as there was no way they were going to pay me what I needed- they ended up hiring a candidate with limited CV experience for much less $$. Pretty sure I dodged a bullit. Several red flags: 1. Product: yeah, its "new" and "novel", but it's also uproven, with no compelling clinical data AND it's really just a Zetia knock off- the efficacy is no better. Lots of talk about the fixed dose combo, but they are initially launching the mono product only....if that bombs, will the fdc will follow? This drug will be going head-to-head with generic statins (the most proven drug class ever), ezetimibe (very well establsihed), PCSK9i- Amgen and Repatha, and soon, inclisiran, from Novartis- 2x/year, very cost effective, and the agent cardiologists are really waiting for. Sounds like an uphill battle- espeically for a start-up with limited $ and resources. 2. Process: the interview process was completely superficial- very little about the drug, clinical data (not much there) or disease state (other than something we already know: lots of people aren't at their LDL goals). Had 2 interviews and all they wanted to know was what I was going to do on day one, including the names of clinics and doctors I would call on, and, how many scripts I would bring in the first week, month and at 90 days. They want you to believe the culture won't be "big pharma" or about "metrics", but that's exectly what it will be- the pressure is going to be constant and intense. Furthermore, during the second interview, with a couple dudes who were supposed to be "regional" or "national" managers, they were feverishly writing down doctors names as I said them. When was the last time this happened to you in an interview? Lame? Desparate? Unprofessional? All of the above. 3. Company: from everyhting I can tell, they barely have enough capital to launch, and they are going to need huge Rx volume out of the gate to keep it going. Keep in mind- new company, one drug, competing in a crowded, highly competitive, highly clinical, cost sensitive space. Finally, and maybe most importantly, the whole thing is being run by LAWYERS- a handful of people who have invested (supposedly) 10 years of their lives into this thing. Bottom line: they want their time and money back ASAP, and they'll do/say anything to get the company to the point where they can sell it off, and that will be that. My take: be afriad and stay away.